Serogroup B meningococcal disease: new outbreaks, new strategies

Editorial

J D Wenger. JAMA. 1999.

. 1999 Apr 28;281(16):1541-3.

doi: 10.1001/jama.281.16.1541.

No abstract available

Comment on

Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M, Fleming D. Diermayer M, et al. JAMA. 1999 Apr 28;281(16):1493-7. doi: 10.1001/jama.281.16.1493. JAMA. 1999. PMID: 10227318
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Høiby EA, Holst J, Nøkleby H, Rosenqvist E, Sierra G, Campa C, Sotolongo F, Vega J, Garcia J, Herrera P, Poolman JT, Perkins BA. Tappero JW, et al. JAMA. 1999 Apr 28;281(16):1520-7. doi: 10.1001/jama.281.16.1520. JAMA. 1999. PMID: 10227322 Clinical Trial.